|
Video: What is a Stock Split?
|
|
Generation Bio is a genetic medicines company providing durable, redosable treatments for potentially various of patients living with rare and prevalent diseases. Co.'s non-viral genetic medicine platform incorporates its DNA construct called closed-ended DNA; its cell-targeted lipid nanoparticle delivery system; and its capsid-free manufacturing process that uses its proprietary cell-free rapid enzymatic synthesis, to produce ceDNA. Using Co.'s platform, it is developing genetic medicines to provide targeted delivery of genetic payloads that include large and multiple genes to a range of cell types across a range of diseases. According to our Generation Bio stock split history records, Generation Bio has had 0 splits. | |
|
Generation Bio (GBIO) has 0 splits in our Generation Bio stock split history database.
Looking at the Generation Bio stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Generation Bio shares, starting with a $10,000 purchase of GBIO, presented on a split-history-adjusted basis factoring in the complete Generation Bio stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/15/2020 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$22.88 |
|
End price/share: |
$3.70 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-83.83% |
|
Average Annual Total Return: |
-38.22% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,616.81 |
|
Years: |
3.78 |
|
|
|
|
|